Study guide
6.2 Serum, Plasma, Whole Blood, and Anticoagulation
AMT Certified Medical Laboratory Assistant CMLA
Track your progress as you read
Finished sections get a check mark.
1 Introduction
1.1 Current Exam Facts 1.2 Blueprint Weights and Study Strategy
2 Chapter 2: Safety Terminology and Infection Control
2.1 Safety, Infection, and OSHA Terminology 2.2 Chain of Infection and Precautions 2.3 Isolation, Aseptic Technique, and Disease Prevention
3 Chapter 3: OSHA, HazCom, and Public-Health Reporting
3.1 OSHA Bloodborne Pathogens and Needlestick Safety 3.2 Hazard Communication, SDS, and GHS 3.3 Mandated Safety Rules and Public-Health Reporting
4 Chapter 4: Quality Assessment and Quality Control
4.1 Quality Control and Assessment Terminology 4.2 QC vs QA, Internal vs External QC, and Proficiency Testing 4.3 Daily QC, Temperature Logs, and Corrective Action 4.4 Instrument Maintenance and Calibration in CMLA Scope
5 Chapter 5: Waived-Test Integrity and Confirmatory Testing
5.1 Off-Label Waived Testing and High-Complexity Default 5.2 Following Manufacturer Instructions for Waived Tests 5.3 Confirmatory and Supplemental Testing
6 Chapter 6: Phlebotomy Foundations
6.1 Phlebotomy Terminology and Equipment 6.2 Serum, Plasma, Whole Blood, and Anticoagulation 6.3 Patient Identification and Container Identification
7 Chapter 7: Venipuncture, Order of Draw, and Specimen Integrity
7.1 Patient Preparation and Physiologic Effects 7.2 Vein Selection and Venipuncture Technique 7.3 Order of Draw and Tube Additives 7.4 Short Draws, Hemolysis, and Plasma-on-Cells Limits
8 Chapter 8: Capillary Collection, Processing, and Legal Specimens
8.1 Capillary Puncture Including Infants 8.2 Post-Care, Labeling, Transport, Processing, and Send-Outs 8.3 Specimens Used as Legal Evidence
9 Chapter 9: Non-Blood Collection and Preanalytical Errors
9.1 Urine Collection Types and Patient Instruction 9.2 Urine Suitability, Storage, Preservatives, and Rejection 9.3 Other Specimens and Time/Temperature Requirements 9.4 Shipping, Slide Prep, Preanalytical Errors, and Complications
10 Chapter 10: Clinical Chemistry
10.1 Clinical Chemistry Terminology and Test Families 10.2 Chemistry Instrumentation, Cleaning, and Maintenance 10.3 Point-of-Care and Waived Chemistry Testing 10.4 Toxicology Within CMLA Scope
11 Chapter 11: Hematology and Coagulation
11.1 Hematology Terminology, Blood Functions, and Cell Types 11.2 Hematology Instrumentation, QC, and Calibration 11.3 Coagulation: PT, PTT, INR, Heparin, and Warfarin 11.4 Point-of-Care and Waived Hematology Tests
12 Chapter 12: Immunology, Serology, and Immunohematology
12.1 Antigen-Antibody Principles 12.2 Blood Types, Rh, and Immunohematology Basics 12.3 Waived Immunology, Serology, and Immunohematology Procedures
13 Chapter 13: Microbiology
13.1 Microbiology Terminology and Specimen Appropriateness 13.2 Aseptic Processing, Storage, and Transport of Micro Specimens 13.3 Media, Cultures, and Procedure Matching 13.4 Stains, KOH, Wet Preps, Reagents, and Controls
14 Chapter 14: Urinalysis and Microscopy
14.1 Urinalysis Terminology 14.2 Waived Urinalysis Procedures and Specimen Handling 14.3 Microscopy Parts, Magnification, Wet Prep, and Cleaning
15 Chapter 15: Basic Anatomy and Physiology
15.1 Anatomy Relevant to Laboratory Testing 15.2 Physiology Relevant to Laboratory Testing
16 Chapter 16: Legal, Ethical, and HIPAA Foundations
16.1 Consent, ABN, Test Ordering, and PPM Restrictions 16.2 Patient's Bill of Rights, Refusal, and Medicolegal Risk 16.3 Professional Appearance, Conduct, and Social Media 16.4 HIPAA Confidentiality and Record Release
17 Chapter 17: Clerical Skills, Communication, and Critical Values
17.1 Reports, Abnormal Results, and Critical-Value Notification 17.2 HIT Data, Inventory, Expirations, and Billing/Coding 17.3 Patient Instruction, Communication, Telephone, and Time Management
6.2 Serum, Plasma, Whole Blood, and Anticoagulation
Key Takeaways Explain This Topic AI
Serum is the liquid remaining after blood clots (fibrinogen is consumed in the fibrin clot); plasma is the liquid portion of anticoagulated blood and still contains fibrinogen.
Whole-blood assays such as a complete blood count (CBC) require mixed, unclotted blood with cells left in suspension; they cannot be performed on serum.
EDTA chelates calcium (hematology); sodium citrate binds calcium at a 9:1 blood-to-anticoagulant ratio (coagulation); heparin inhibits thrombin (plasma chemistry); fluoride/oxalate inhibits glycolysis for glucose.
Invert anticoagulant tubes the manufacturer-specified number of times immediately after fill; shaking hemolyzes cells, and skipped mixing leaves residual clots.
Gel-separator tubes (SST or PST) form a barrier after centrifugation so cells do not continue to metabolize analytes in the liquid.
Last updated: August 2026
AMT lists three related competencies together: know the differences among serum , plasma , and whole blood (II.3.A.2); understand clotted versus anticoagulated blood (II.3.A.3); and use the proper anticoagulant for each analysis, including the effects of the wrong one (II.3.B.3). Order of draw, short draws, and hemolysis are Chapter 7. This section is the foundation those later items sit on: if you cannot say whether a test needs cells, clotting factors, or a cell-free liquid, you will pick the wrong tube even if you recite colors in the correct sequence.
Quick Answer: Whole blood = cells plus liquid, kept from clotting. Plasma = liquid from anticoagulated blood (fibrinogen still there). Serum = liquid after a clot forms (fibrinogen used up). Mix anticoagulant tubes by gentle inversion. EDTA is hematology, citrate is coagulation, heparin is plasma chemistry, fluoride/oxalate preserves glucose.
Whole blood, plasma, and serum
Whole blood is the specimen as it circulates: erythrocytes, leukocytes, and platelets suspended in liquid. For laboratory use, whole blood must be mixed with an anticoagulant so it does not clot, and it must be mixed again before testing so cells do not settle. A complete blood count (CBC), blood-film review, many point-of-care glucose meters, and most waived whole-blood immunoassays are whole-blood tests. If the tube clots, the specimen is no longer whole blood for those assays.
Plasma is the liquid portion of blood that still contains fibrinogen and the other coagulation proteins. You obtain plasma by drawing into an anticoagulant, mixing, then centrifuging to sediment the cells. The supernatant is plasma.
Serum is the liquid remaining after blood has been allowed to clot . During clotting, fibrinogen is converted to fibrin and is trapped in the clot with the cells. After centrifugation, the supernatant is serum: it lacks fibrinogen. Many chemistry, serology, and blood-bank antibody methods are validated on serum. They are not automatically validated on plasma, and plasma methods are not automatically validated on serum. Using the wrong liquid is an off-label specimen type (Chapter 5) as well as a preanalytical error.
- Feature Whole blood Plasma Serum
- Cells present Yes, in suspension No (spun down) No (trapped in the clot, then spun)
- Fibrinogen Present (until a clot forms) Present Consumed in the clot
How you get it Anticoagulant, mixed, not used as a cell-free liquid Anticoagulant, mixed, centrifuged No anticoagulant or clot activator, clot, centrifuge
Typical assays CBC, some POC glucose and A1C, many waived whole-blood kits Coagulation (citrate plasma); many chemistry panels (heparin plasma) Many chemistry and serology methods
Fatal mix-up Clotted EDTA is not a CBC Calling serum plasma because both look yellow Sending plasma for a serum-only method
Visual color does not identify the specimen. Fresh plasma and serum can both be straw-yellow. The tube additive and whether a clot formed are what distinguish them.
How a clot forms
Hemostasis in the tube follows the same idea as in the patient. Platelets aggregate, the coagulation cascade activates, thrombin converts fibrinogen to fibrin , and a fibrin mesh locks cells into a clot. In a red-top or gold/tiger serum-separator tube there is no anticoagulant (gold/tiger tubes add a clot activator). Blood sits until the clot is complete—commonly about 30 minutes at room temperature, following the manufacturer's instructions for use (IFU). Centrifuging too early leaves fibrin strands in the serum (a latent clot) that clog pipettors and invalidate results. Centrifuging after a full clot, then keeping serum on the cells without a barrier, lets cells continue to metabolize glucose and leak potassium; Chapter 7 covers plasma-on-cells time limits. The CMLA point here is mechanical: no anticoagulant + time = clot = serum .
Clotted versus anticoagulated blood
Clotted blood has formed a fibrin clot. The liquid is serum. You cannot resuspend that specimen into whole blood by shaking it. Clotted EDTA or clotted citrate tubes are rejected for hematology and coagulation; they are not a creative source of serum unless the laboratory's procedure explicitly allows a conversion that CMLA should not invent.
Anticoagulated blood has an additive that blocks clotting so cells remain free. After centrifugation, the liquid is plasma. If mixing is skipped, microscopic clots still form: platelet clumps flag a CBC, and a citrate tube with residual clots invalidates PT and aPTT. Anticoagulated is a process (right additive plus immediate mixing), not a stopper color you glance at on the way to the centrifuge.
Why gel separators exist
A serum separator tube (SST) (gold or tiger-top) contains clot activator and a thixotropic gel. After clotting and centrifugation, the gel lodges between the clot and the serum. A plasma separator tube (PST) (light-green lithium heparin) does the same between cells and plasma. The barrier stops cells from eating glucose and leaking potassium and lactate dehydrogenase into the liquid during delays. Gel is not an anticoagulant. An SST still must clot; a PST still must be mixed. Do not assume every green or gold tube is interchangeable with a non-gel tube of similar color—the IFU and the test menu decide.
Why inversion mixing matters
Anticoagulant is concentrated in the tube before blood enters. If the tube stands unmixed, the first milliliter meets a bolus of additive and the last milliliter may never see it. Invert —gentle complete turns, wrist to wrist—the number of times the manufacturer and CLSI specify, immediately after the tube fills. Typical teaching numbers are about 3–4 inversions for citrate and 8–10 for EDTA, heparin, and fluoride; clot-activator serum tubes are inverted about 5 times to mix the activator, then left upright to clot. Those counts are a memory aid; the IFU wins if it differs.
Shaking is not mixing. Shaking shears red cells and causes hemolysis , which falsely raises potassium, lactate dehydrogenase, and aspartate aminotransferase and can invalidate many assays. Hemolysis mechanics are Chapter 7; the foundation is that inversion distributes additive without destroying cells.
EDTA, citrate, heparin, and oxalate/fluoride
Define each additive by mechanism and job . Tube-color order of draw is Chapter 7; you still must know what is in the tube because II.3.B.3 tests improper anticoagulant use.
Additive Mechanism Typical tube job What goes wrong if you use it for the wrong test
EDTA (ethylenediaminetetraacetic acid; K2 or K3) Chelates (binds) calcium so the cascade cannot run Hematology: CBC, differential, hemoglobin A1C in many methods, blood bank EDTA samples Falsely low calcium and magnesium; K-EDTA falsely high potassium; unacceptable for coagulation
Sodium citrate Binds calcium; calibrated 9:1 blood-to-anticoagulant fill Coagulation: PT, aPTT, INR Underfill over-anticoagulates and prolongs times; citrate is not the CBC anticoagulant of choice and dilutes cell counts
Heparin (lithium or sodium salt) Potentiates antithrombin; inhibits thrombin Plasma chemistry (PST); some special assays Contaminates coagulation tests (falsely prolonged PT/aPTT); sodium heparin can affect sodium results
Potassium oxalate plus sodium fluoride Oxalate binds calcium (anticoagulant); fluoride inhibits glycolysis (preservative) Glucose, lactate, some alcohol collections per IFU Oxalate damages cells and can interfere with enzymes and electrolytes; fluoride is a preservative, not a hematology anticoagulant
EDTA is the hematology workhorse because cell morphology holds and platelets are stable when mixed. It is the wrong tube for ionized calcium or a chemistry panel that reports potassium and calcium.
Citrate exists for coagulation: the laboratory adds back a measured amount of calcium to start the assay. That is why the fill line is not decorative. A short citrate draw is a different error from a wrong additive, but both ruin the result.
Heparin keeps plasma chemistry moving without waiting for a clot. It is not a substitute citrate tube for a heparinized patient who needs aPTT monitoring—the additive heparin in the tube is not the same problem as therapeutic heparin, but either way you cannot run a valid aPTT on a heparin-plasma chemistry tube.
Fluoride is the preservative half of the gray-top pair: it blocks enzymes in the glycolytic path so glucose stops falling after the draw. Oxalate is the anticoagulant half. Calling fluoride an anticoagulant is the terminology miss; calling oxalate a glucose preservative is the matching miss.
Wrong anticoagulant: preview of the harm
II.3.B.3 will return in Chapter 7 with fill volume and order of draw. The conceptual harm starts here:
EDTA chemistry tube: chelated calcium reads low; potassium from K-EDTA reads high; iron and alkaline phosphatase can be distorted.
Heparin coagulation tube: thrombin is inhibited in the tube, so PT and aPTT do not reflect the patient.
Citrate CBC: extra liquid dilutes hemoglobin, hematocrit, and cell counts; morphology is not EDTA-quality.
Serum tube submitted for CBC or PT: it clots; platelets are consumed; the analyzer flags clumps or the test cannot be performed.
Fluoride/oxalate submitted for potassium or enzyme panels: cell damage and enzyme inhibition.
Unmixed EDTA: residual microclots, falsely low platelet count (pseudothrombocytopenia) or instrument flags.
The assistant action is the same for every row: do not pour blood from one additive tube into another to salvage a missed tube, and do not relabel a wrong-color tube as the test the nurse wanted . Recollect in the correct container.
In practice
A provider orders a CBC, basic metabolic panel, and PT. You understand the metabolic panel may be serum or lithium-heparin plasma per the laboratory directory, the CBC must be EDTA whole blood, and the PT must be a full citrate plasma tube. You mix each additive tube by inversion as it comes off the needle. You do not shake, you do not pour EDTA into the citrate tube when the blue top underfills, and you do not centrifuge the EDTA tube to make serum for chemistry.
Exam traps
Serum and plasma are not synonyms because both are yellow liquids.
Whole blood is not plasma with the cells left in out of laziness; it is a different validated specimen.
Gel does not replace anticoagulant or clot time.
Fluoride preserves glucose; EDTA chelates calcium; heparin inhibits thrombin; citrate is the 9:1 coagulation additive.
Shaking is not thorough mixing.
When a stem names a specimen type, answer with fibrinogen, cells, and the additive mechanism—not with a color you memorized without the job.